Xenia Serrat
L'hospitalet De Llobregat, CT 08908, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment.
Journal: NAR cancer
Published: October 17, 2024
Identification of a family of species-selective complex I inhibitors as potential anthelmintics.
Journal: Nature communications
Published: August 22, 2023
Identification of enzymes that have helminth-specific active sites and are required for Rhodoquinone-dependent metabolism as targets for new anthelmintics.
Journal: PLoS neglected tropical diseases
Published: June 11, 2021
Mimicking of splicing-related retinitis pigmentosa mutations in C. elegans allow drug screens and identification of disease modifiers.
Journal: Human molecular genetics
Published: September 17, 2019
CRISPR editing of sftb-1/SF3B1 in Caenorhabditis elegans allows the identification of synthetic interactions with cancer-related mutations and the chemical inhibition of splicing.
Journal: PLoS genetics
Published: July 12, 2019
Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin.
Journal: Disease models & mechanisms
Published: January 08, 2018
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.
Journal: Oncogene
Published: March 10, 2016
Modeling of autosomal-dominant retinitis pigmentosa in Caenorhabditis elegans uncovers a nexus between global impaired functioning of certain splicing factors and cell type-specific apoptosis.
Journal: RNA (New York, N.Y.)
Published: July 23, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026